Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Epizootic Bovine Abortion Vaccine
- Development stage
- Unknown
- Lead developer
- Hygieia Biological Laboratories
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Administration
- Subcutaneous
01
Overview
The Epizootic Bovine Abortion Vaccine (EBAV) is a live-attenuated veterinary vaccine developed by Hygieia Biological Laboratories in collaboration with researchers at the University of California, Davis. It is specifically designed to prevent Epizootic Bovine Abortion (EBA), commonly known as Foothill Abortion, a significant cause of reproductive loss in beef cattle in the intermountain West of the United States. The disease is caused by the bacterium *Pajaroellobacter abortivus*, which is transmitted to cattle by the Pajaroello tick (*Ornithodoros coriaceus*). The vaccine contains a live, weakened form of the *Pajaroellobacter abortivus* agent and is administered to heifers at least 60 days prior to breeding to allow for the development of a protective immune response, thereby preventing late-term fetal loss and abortion during pregnancy.
- Brand names
- EBAV
- Other names
- Foothill Abortion VaccinePajaroellobacter abortivus vaccineEBA vaccine
Beyond the preview
Go deeper on Epizootic Bovine Abortion Vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Epizootic Bovine Abortion Vaccine.